JENSCARE-B (09877.HK): CSRC Filing Notice for H Share Full Circulation
NewTimeSpace News: On 19 November 2026, Jenscare Scientific Co., Ltd. (stock code: 09877.HK) said it had submitted a filing application to the China Securities Regulatory Commission (CSRC) on behalf of certain shareholders for the implementation of H share full circulation, involving the conversion of an aggregate of 74,227,021 domestic shares and unlisted foreign shares into H shares and the listing of those shares on the Stock Exchange. The Company has recently received the CSRC's Notice of the Full Circulation Registration of the Domestic Unlisted Shares of Jenscare Scientific Co., Ltd. in respect of the conversion and listing.
As at the date of the announcement, details of the implementation plan for the H share full circulation and the conversion and listing have not been finalised. The Company will make further announcements on progress in accordance with the Inside Information Provisions and the Listing Rules.
The Company cautioned that completion of the H share full circulation and the conversion and listing is subject to other procedures required by the Stock Exchange and other domestic and overseas regulatory authorities, and advised shareholders and potential investors to exercise caution when dealing in its securities.
- JENSCARE-B (09877.HK) : presents LuX-Valve Plus trial results at TCT 2026
- JENSCARE-B (09877.HK): LuX-Valve Plus Completes First Implantations in FDA US Pivotal Trial
- JENSCARE-B(09877.HK): LuX-Valve Plus Transcatheter Tricuspid Valve Replacement System Secures EU MDR CE Certification
- Jenscare-B(09877.HK):Ken-Valve Transcatheter Aortic Valve System Obtains Listing Approval from Hong Kong Department of Health
- Premia CSI Caixin China New Economy ETF (03173.HK) Rises 2.12% to HKD 10.620